Hyperhomocystenemia as a Risk Factor for Ischemic Stroke

被引:0
作者
Fatima, Shahzeen [1 ]
Memon, Salma Farrukh [2 ]
Ansari, Asmat Kamal [3 ]
Baloch, Abdul Hafeez [4 ]
机构
[1] Isra Univ Hyderabad, Physiol, Hyderabad, Sindh, Pakistan
[2] LUMHS, Physiol, Jamshoro, Sindh, Pakistan
[3] Dewan Med & Dent Coll, Physiol, Karachi, Sindh, Pakistan
[4] Al Tibri Med Coll, Anat, Karachi, Sindh, Pakistan
来源
JOURNAL OF THE LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES | 2012年 / 11卷 / 03期
关键词
Homocysteine; Stroke; Risk factors;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
OBJECTIVES: This study was carried out to evaluate homocysteine as a risk factor for ischemic stroke. DESIGN: Descriptive study SETTING: Isra University & Liaquat university of Medical and health sciences Jamshoro (LUMHS). STUDY DESIGN: Twenty five diagnosed cases of ischemic stroke were selected from different wards of two hospitals. Twenty five healthy age matched persons were taken as controls having no risk factors for stroke. Serum homocysteine level was determined by enzyme immunoassay using commercially available kit. RESULTS: Serum homocysteine level in patients with stroke was 14.0 + 1.9 mu mol/Lit and in healthy controls it was 9.0 + 0.58 mu mol/Lit. There was statically significant difference (p < 0.05) in the homocysteine level between the two groups yet the level was within normal range. CONCLUSION: Serum homocysteine level is significantly increased in patients with ischemic stroke as compared to the normal healthy individuals having no ischemic stroke risk factors.
引用
收藏
页码:158 / 161
页数:4
相关论文
共 17 条
[1]   Homocysteine and lipoprotein (a) correlation in ischemic stroke patients [J].
Dhamija, Rajinder K. ;
Gaba, P. ;
Arora, S. ;
Kaintura, A. ;
Kumar, M. ;
Bhattacharjee, J. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 281 (1-2) :64-68
[2]   Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke [J].
Eikelboom, JW ;
Hankey, GJ ;
Anand, SS ;
Lofthouse, E ;
Staples, N ;
Baker, RI .
STROKE, 2000, 31 (05) :1069-1075
[3]  
Erenoglu NY, 2005, J NEUROL SCI, V22, P394
[4]   Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction [J].
Hassan, A ;
Hunt, BJ ;
O'Sullivan, M ;
Bell, R ;
D'Souza, R ;
Jeffery, S ;
Bamford, JM ;
Markus, HS .
BRAIN, 2004, 127 :212-219
[5]   Hyperhomocysteinemia, vascular function and atherosclerosis: Effects of vitamins [J].
Haynes, WG .
CARDIOVASCULAR DRUGS AND THERAPY, 2002, 16 (05) :391-399
[6]   Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients [J].
Ho, GYH ;
Eikelboom, JW ;
Hankey, GJ ;
Wong, CR ;
Tan, SL ;
Chan, JBC ;
Chen, CPLH .
STROKE, 2006, 37 (02) :456-460
[7]  
Iso H, 2004, AM HEART ASS J, V27, P2766
[8]  
Khealan AB, 2008, J PAK MED ASSOC, V58, P400
[9]   Efficacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke Prevention A Meta-Analysis [J].
Lee, Meng ;
Hong, Keun-Sik ;
Chang, Shen-Chih ;
Saver, Jeffrey L. .
STROKE, 2010, 41 (06) :1205-1212
[10]  
Modi M, 2005, NEUROL INDIA, V53, P297